Search
ProShares Ultra Nasdaq Biotechnology
BIBAdd to Watchlist
117.735USD
+5.071+4.50%
Close 11-06 16:00（ET）
0.00Volume
0.00Turnover
Today
+4.50%
5 Days
-2.32%
1 Month
+9.56%
6 Months
+42.78%
Year to Date
+47.69%
1 Year
+69.75%
Key Figures
112.000Open
112.664Prev. Close
118.034High
112.000Low
0.00Volume
0Turnover
0.81Volume Ratio
126.31052wk High
70.09052wk Low
9.77KAvg Volume
0.22%Div Yield
0.224Est. Annual Div.
Health CareInvestment Segment
NoInverse ETF
YesLeveraged ETF
2xLeverage Factor
110.290NAV
USDNAV Currency
--P/B
--Price to earnings ratio
ProShares Ultra Nasdaq Biotechnology Profile
Ticker SymbolBIB
Asset ClassEquity
Fund ManagerProShares
DomicileUS
Expense Ratio0.95%
Founded at2010-04-07
Tracking IndexNASDAQ / Biotechnology
BIB was created on 2010-04-07 by ProShares. The fund's investment portfolio concentrates primarily on health care equity. BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.
Top 10 Holdings
No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
PROSHARES GENIUS MONEY MARKET ETF
IQMM
100.130
+0.020
+0.02%
170.00K
0.00%
$17.02M
GILEAD SCIENCES INC
GILD
166.890
-0.680
-0.41%
33.34K
5.49%
$5.20M
AMGEN INC
AMGN
460.420
+0.140
+0.03%
11.35K
5.26%
$4.99M
4
VERTEX PHARMACEUTICALS INC
VRTX
547.090
+4.590
+0.85%
8.96K
4.95%
$4.69M
5
REGENERON PHARMACEUTICALS
REGN
904.350
+1.450
+0.16%
4.04K
3.43%
$3.25M
6
MODERNA INC
MRNA
254.190
+12.730
+5.27%
15.95K
3.36%
$3.19M
7
ILLUMINA INC
ILMN
213.130
+5.130
+2.47%
6.03K
1.71%
$1.62M
8
REVOLUTION MEDICINES INC
RVMD
192.280
+14.630
+8.24%
8.56K
1.69%
$1.60M
9
BIOGEN INC
BIIB
248.350
+4.420
+1.81%
5.90K
1.56%
$1.48M
10
ALNYLAM PHARMACEUTICALS INC
ALNY
155.940
-0.720
-0.46%
5.34K
1.26%
$1.20M
ProShares Ultra Nasdaq Biotechnology Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Buy
ProShares Ultra Nasdaq Biotechnology News
More news coming soon, stay tuned...
Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of ProShares Ultra Nasdaq Biotechnology (BIB)?
The current price of ProShares Ultra Nasdaq Biotechnology (BIB) is 110.32. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of ProShares Ultra Nasdaq Biotechnology?
The 52-week high of ProShares Ultra Nasdaq Biotechnology is 126.31. Please refer to the page timestamp for the latest data.
What is the 52-week low of ProShares Ultra Nasdaq Biotechnology?
The 52-week low of ProShares Ultra Nasdaq Biotechnology is 67.34. Please refer to the page timestamp for the latest data.
Is ProShares Ultra Nasdaq Biotechnology (BIB) a safe investment?
No investment is completely risk-free. The risk level of ProShares Ultra Nasdaq Biotechnology (BIB) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.